NASDAQ:HBIO - Harvard Bioscience Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$2.40 -0.08 (-3.23 %)
(As of 05/22/2019 03:48 AM ET)
Previous Close$2.48
Today's Range$2.40 - $2.49
52-Week Range$2.26 - $6.70
Volume217,500 shs
Average Volume145,713 shs
Market Capitalization$90.45 million
P/E Ratio16.00
Dividend YieldN/A
Beta1.33

Analyst Ratings

Harvard Bioscience (NASDAQ:HBIO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Harvard Bioscience in the last 12 months. Their average twelve-month price target is $11.00, suggesting that the stock has a possible upside of 358.33%. The high price target for HBIO is $11.00 and the low price target for HBIO is $11.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.00$11.00$11.00$9.50
Price Target Upside: 358.33% upside187.96% upside187.96% upside77.57% upside

Harvard Bioscience (NASDAQ:HBIO) Consensus Price Target History

Price Target History for Harvard Bioscience (NASDAQ:HBIO)

Harvard Bioscience (NASDAQ:HBIO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/18/2019Janney Montgomery ScottReiterated RatingBuyLowView Rating Details
6/30/2018BenchmarkInitiated CoverageBuy$11.00LowView Rating Details
(Data available from 5/22/2017 forward)
This page was last updated on 5/22/2019 by MarketBeat.com Staff

Featured Article: What is a trade deficit?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel